Major Pharmaceuticals recalls

Major Pharmaceuticals has 19 recalls on record with the FDA and USDA, the earliest in 2018 and the latest reported on 29 Jul 2026. 12 are still ongoing. 12 were reported in the last 12 months. The most frequent reason is potency & assay.

Total recalls19since 2018

Last 12 months12reported

Class I00% of total

Ongoing12latest 29 Jul 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 12Jul 0 0

Severity split

Class I 0 0%Class II 17 89%Class III 2 11%

Why major pharmaceuticals is recalled

Product types

Brands

By year

20261263%
2019211%
2018526%

Ongoing major pharmaceuticals recalls

12 active

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg 0150 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg 050 mg) dose blisters recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg 0125 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg 0112 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg 025 mg) dose blisters recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg 050 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide

All major pharmaceuticals recalls, newest first

19 total

Reported	Class	Recall	Company	Reason	Where
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 150 mcg 0150 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg 050 mg) dose blisters recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 125 mcg 0125 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 112 mcg 0112 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg 025 mg) dose blisters recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 50 mcg 050 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 25 mcg 025 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets recalled by Major PharmaceuticalsLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 75 mcg 075 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide
29 Jul 2026Drug	CLASS II	Levothyroxine Sodium Tablets, USP, 88 mcg 088 mg) recalledLevothyroxine Sodium	Major Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.